Croyle David J
Chief Medical Officer
Croyle David J has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 26, 2026.
On the most recent filing, Croyle David J is listed as Chief Medical Officer at CALLAN JMB INC. Inside the rolling window, Croyle David J reported 2 open-market purchases totaling $44K in CJMB and no open-market sales. The largest disclosed transaction in the window is a purchase of 14,805 CJMB shares on Mar 6, 2026, worth $26K.
Companies traded
Other insiders at CJMB
Insider Buying
$44K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Croyle David J made?
Croyle David J has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Croyle David J trade?
Croyle David J has filed SEC Form 4 disclosures for 1 company, including CJMB.
When was Croyle David J's most recent SEC Form 4 filing?
Croyle David J's most recent SEC Form 4 filing on Tracefour is dated Mar 26, 2026.
What is Croyle David J's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Croyle David J is listed as Chief Medical Officer.
What is Croyle David J's total buy and sell value in the current window?
Inside the rolling retention window, Croyle David J bought $44K and sold $0 based on SEC Form 4 filings.
What was Croyle David J's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 14,805 CJMB shares on 2026-03-06, worth $26K, per SEC Form 4 filings.